Your shopping cart is currently empty

Clarithromycin-d3 is the deuterium-labeled form of Clarithromycin, which exhibits broad-spectrum antibacterial activity. It inhibits CYP3A4-catalyzed triazolam α-hydroxylation, with an IC50 (Ki) value of 56 (43) μM. Additionally, Clarithromycin significantly inhibits HERG potassium currents and affects autophagic flux by disrupting the signaling pathway linking hERG1 and PI3K.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Clarithromycin-d3 is the deuterium-labeled form of Clarithromycin, which exhibits broad-spectrum antibacterial activity. It inhibits CYP3A4-catalyzed triazolam α-hydroxylation, with an IC50 (Ki) value of 56 (43) μM. Additionally, Clarithromycin significantly inhibits HERG potassium currents and affects autophagic flux by disrupting the signaling pathway linking hERG1 and PI3K. |
| Molecular Weight | 750.97 |
| Formula | C38H69NO13 |
| Cas No. | 959119-22-3 |
| Smiles | O([C@H]1[C@@](OC)(C)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@](OC)(C)[C@@H](O)[C@H](C)O2)[C@@H]1C)[C@H]3[C@H](O)[C@@H](N(C([2H])([2H])[2H])C)C[C@@H](C)O3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.